Merck logo

Merck

Stock
Stock
ISIN: DE0006599905
Ticker: MRK
DE0006599905
MRK

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Merck has so far distributed $2.569 in 2026. The next dividend will be paid on 29.04.2027


$1.428

CHART BY

Frequently asked questions

The market capitalization of Merck is $64.59B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Merck is 23.82. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Merck's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.236. EPS indicates the company's profitability on a per-share basis.
Currently, 16 analysts cover Merck's stock, with a consensus target price of $175.61. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Merck reported a revenue of $24.18B.
Merck's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $7.54B. EBITDA measures the company's overall financial performance.
Merck has a free cash flow of $3.12B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Merck employs approximately 62,461 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
The free float of Merck is 129.24M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$64.59B
EPS (TTM) 
$6.236
Free Float 
129.24M
P/E ratio (TTM) 
23.82
Revenue (TTM) 
$24.18B
EBITDA (TTM) 
$7.54B
Free Cashflow (TTM) 
$3.12B

Pricing

1D span
$151.02$153.39
52W span
$116.96$171.47

Analyst Ratings

The price target is $175.61 and the stock is covered by 16 analysts.

Buy

9

Hold

7

Sell

0

Information

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Employees
62,461
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
DE0006599905
Primary Ticker
MRK

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation